Ipilimumab-related hypophysitis may precede severe CNS immune attack

Reintroduction of ipilimumab after recovery or hormonal substitution for hypophysitis should be carefully done especially in the presence of minor neurological symptoms or signs (such as tinnitus) which should be considered as red flags for subsequent severe central nervous immune attack.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2016-10, Vol.27 (10), p.1975-1976
Hauptverfasser: Köessler, T., Olivier, T., Fertani, S., Marinari, E., Dutoit, V., Dietrich, P.-Y.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Reintroduction of ipilimumab after recovery or hormonal substitution for hypophysitis should be carefully done especially in the presence of minor neurological symptoms or signs (such as tinnitus) which should be considered as red flags for subsequent severe central nervous immune attack.
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdw255